AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8351679 — intervention group
Group type: COMPARATOR
Intervention: Ethyl biscoumacetate (300 mg) alone
Number of subjects: 6
Study 3529921 — intervention group
Group type: EXPERIMENTAL
Intervention: estramustine phosphate (EMP)
Number of subjects: 236
Study 3529921 — intervention group
Group type: COMPARATOR
Intervention: diethylstilbestrol (DES)
Number of subjects: 236
Study 29038286 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-aortic MSCs (AC607; n=67)
Number of subjects: 156
Study 29038286 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=68)
Number of subjects: 156
Study 29038286 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-aortic MSCs (AC607)
Number of subjects: 156
Study 29038286 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study 27768503 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption (0.88g ethanol/kg body weight)
Number of subjects: 8
Study 27768503 — intervention group
Group type: COMPARATOR
Intervention: Iso-caloric placebo
Number of subjects: 8
Study 27768503 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 8
Study 26437311 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 session cognitive behavioral therapy (IPaViT‐CBT) group intervention
Number of subjects: 14
Study 26437311 — intervention group
Group type: COMPARATOR
Intervention: treatment as usual
Number of subjects: 14
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga-based Psychotherapy Group
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: MindBody Course
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga and Stress Management Intervention
Number of subjects: 0
Study 24176784 — intervention group
Group type: COMPARATOR
Intervention: Yoga
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic Yoga Program
Number of subjects: 0
Study 24176784 — intervention group
Group type: COMPARATOR
Intervention: Yoga and Life Skills Eating Disorder Prevention
Number of subjects: 0
Study 24176784 — intervention group
Group type: COMPARATOR
Intervention: Yoga and Physical Education
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga and Wellness Education
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Kundalini Mantra and Meditation
Number of subjects: 0
Study 24176784 — intervention group
Group type: COMPARATOR
Intervention: Kundalini Yoga Therapy
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga Programs for Smoking Cessation
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Pranayam Practice
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored Yoga Program
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga-based Intervention
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga-based Interventions
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga Therapy Adapted for Older Veterans
Number of subjects: 0
Study 24176784 — intervention group
Group type: COMPARATOR
Intervention: Yoga for Women With Major Depressive Disorder
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga Telehealth Program
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga Practice Frequency
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical Yoga
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Classroom-based Yoga Intervention
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga Therapy
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga and Stress Management
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-systems Ayurveda and Yoga Therapy
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga for Smoking Cessation Treatment
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Program for Female Inmates
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga After Stroke
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-Yoga
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Ashtanga Yoga-based Curriculum
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga for Individuals With Chronic Stroke
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardization of Yoga Interventions
Number of subjects: 0
Study 24176784 — intervention group
Group type: EXPERIMENTAL
Intervention: Africa Yoga Project Teachers
Number of subjects: 0
Study 21484739 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine injections (19 patients)
Number of subjects: 33
Study 21484739 — intervention group
Group type: COMPARATOR
Intervention: Saline injections (14 patients)
Number of subjects: 33
Study 18575447 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive prophylaxis for DVT including Aspirin, fibrinolytic enzyme, passive and active circumduction of the foot and ankle, CPM management
Number of subjects: 157
Study 18575447 — intervention group
Group type: COMPARATOR
Intervention: No thromboproxylaxis (Control group)
Number of subjects: 157
Study 18575447 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive prophylaxis for DVT
Number of subjects: 157
Study 18575447 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 157
Study 16542200 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium bromide 54 mcg
Number of subjects: 30
Study 16542200 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide 40 mcg
Number of subjects: 30
Study 16542200 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 12669007 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Fat Dietary Modification Intervention
Number of subjects: 12030
Study 12669007 — intervention group
Group type: EXPERIMENTAL
Intervention: Added fats
Number of subjects: 12030
Study 12669007 — intervention group
Group type: EXPERIMENTAL
Intervention: Meats
Number of subjects: 12030
Study 12669007 — intervention group
Group type: EXPERIMENTAL
Intervention: Desserts
Number of subjects: 12030
Study 12669007 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 12030
Study 10634377 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (500 mg tid)
Number of subjects: 23
Study 10634377 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 9189734 — intervention group
Group type: EXPERIMENTAL
Intervention: Suberythematous ultraviolet (UV) radiation (groups II and III, 12 radiations in 4 weeks with two different spectra containing UV-B)
Number of subjects: 24
Study 9189734 — intervention group
Group type: COMPARATOR
Intervention: Control (no irradiation, group I)
Number of subjects: 24
Study 1337458 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalaprilat 2.5 mg
Number of subjects: 25
Study 1337458 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 25
Study 1337458 — intervention group
Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 25
Study 1337458 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalaprilat
Number of subjects: 25
Study 1337458 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 30926430 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene glycol plus simethicone (SIM)
Number of subjects: 0
Study 30926430 — intervention group
Group type: COMPARATOR
Intervention: Polyethylene glycol
Number of subjects: 0
Study 28647747 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy for Insomnia (MBCT-I)
Number of subjects: 216
Study 28647747 — intervention group
Group type: COMPARATOR
Intervention: Sleep Psycho-Education with Exercise Control (PEEC)
Number of subjects: 216
Study 28647747 — intervention group
Group type: COMPARATOR
Intervention: Both groups (MBCT-I and PEEC)
Number of subjects: 216
Study 25560366 — intervention group
Group type: EXPERIMENTAL
Intervention: Power Point Presentation (PPT)
Number of subjects: 30
Study 25560366 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercially available software (SW)
Number of subjects: 30
Study 25560366 — intervention group
Group type: COMPARATOR
Intervention: Traditional training (Control group - CF)
Number of subjects: 30
Study 25106761 — intervention group
Group type: EXPERIMENTAL
Intervention: E‐ZES (Endeavour zotarolimus-eluting stent)
Number of subjects: 8791
Study 25106761 — intervention group
Group type: COMPARATOR
Intervention: C‐SES (Cypher sirolimus-eluting stent)
Number of subjects: 8791
Study 25106761 — intervention group
Group type: EXPERIMENTAL
Intervention: E‐ZES
Number of subjects: 8791
Study 25106761 — intervention group
Group type: COMPARATOR
Intervention: C‐SES
Number of subjects: 8791
Study 22296034 — intervention group
Group type: EXPERIMENTAL
Intervention: Repaglinide (3 mg day(-1) for 8 weeks)
Number of subjects: 368
Study 19018143 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe/simvastatin 10/40 mg
Number of subjects: 0
Study 19018143 — intervention group
Group type: COMPARATOR
Intervention: Doubling the dose of low-, medium-, and high-potency statins
Number of subjects: 0
Study 18564433 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant (n = 16)
Number of subjects: 30
Study 18564433 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 14)
Number of subjects: 30
Study 18564433 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant and Control
Number of subjects: 30
Study 15939944 — intervention group
Group type: EXPERIMENTAL
Intervention: Capitated financing for mental health services
Number of subjects: 105
Study 15939944 — intervention group
Group type: COMPARATOR
Intervention: Fee-for-service reimbursement
Number of subjects: 105
Study 11788475 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol
Number of subjects: 27
Study 11788475 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG)
Number of subjects: 27
Study 11788475 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 11788475 — intervention group
Group type: COMPARATOR
Intervention: LNMMA
Number of subjects: 27
Study 10394083 — intervention group
Group type: EXPERIMENTAL
Intervention: Fem7 (oestradiol matrix-type patch) at doses of 25, 50, 75 and 100 microg/24 h, applied once weekly
Number of subjects: 36
Study 7653758 — intervention group
Group type: EXPERIMENTAL
Intervention: Hayek Oscillator with mean chamber pressure at -10 cmH2O
Number of subjects: 5
Study 7653758 — intervention group
Group type: EXPERIMENTAL
Intervention: Hayek Oscillator with mean chamber pressure at -20 cmH2O
Number of subjects: 5
Study 7653758 — intervention group
Group type: EXPERIMENTAL
Intervention: Hayek Oscillator with mean chamber pressure at 0 and -5 cmH2O
Number of subjects: 5
Study 7653758 — intervention group
Group type: EXPERIMENTAL
Intervention: Hayek Oscillator with varying peak-to-trough pressure span
Number of subjects: 5
Study 7653758 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing negative extrathoracic pressure
Number of subjects: 5
Study 2202901 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of beta carotene per day
Number of subjects: 1805
Study 2202901 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1805
Study 7294222 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitored group (urine specimens collected once a week)
Number of subjects: 431
Study 7294222 — intervention group
Group type: COMPARATOR
Intervention: Unmonitored group (no urine specimens collected)
Number of subjects: 431
Study 31504875 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided transversus abdominis plane block (TAPb)
Number of subjects: 96
Study 31504875 — intervention group
Group type: COMPARATOR
Intervention: Standard general anesthetic plus ultrasound-guided TAPb
Number of subjects: 96
Study 31504875 — intervention group
Group type: COMPARATOR
Intervention: Standard general anesthetic (NO-TAP group)
Number of subjects: 96
Study 31894028 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia with propofol
Number of subjects: 98
Study 31894028 — intervention group
Group type: COMPARATOR
Intervention: Simple inhalation anesthesia with sevoflurane
Number of subjects: 98
Study 29273067 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg (IV-300 mg)
Number of subjects: 226
Study 29273067 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg (IV-150 mg)
Number of subjects: 226
Study 29273067 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 226
Study 29273067 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg and 150 mg
Number of subjects: 226
Study 29273067 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab
Number of subjects: 226
Study 26462848 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help with chat
Number of subjects: 308
Study 26462848 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help without chat
Number of subjects: 308
Study 26462848 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 308
Study 24040972 — intervention group
Group type: EXPERIMENTAL
Intervention: Congenitally blind subjects
Number of subjects: 0
Study 24040972 — intervention group
Group type: COMPARATOR
Intervention: Normal-sighted subjects
Number of subjects: 0
Study 21823343 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback (BF)
Number of subjects: 140
Study 21823343 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical Stimulation (ES)
Number of subjects: 140
Study 21823343 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback plus Electrical Stimulation (BF + ES)
Number of subjects: 140
Study 21823343 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 140
Study 19716041 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoral
Number of subjects: 16
Study 19716041 — intervention group
Group type: COMPARATOR
Intervention: Cysporin
Number of subjects: 16
Study 17668973 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP plus 25% metronidazole gel
Number of subjects: 21
Study 17668973 — intervention group
Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 21
Study 15053885 — intervention group
Group type: EXPERIMENTAL
Intervention: Music group (n=99)
Number of subjects: 193
Study 15053885 — intervention group
Group type: COMPARATOR
Intervention: Non-music group (n=94)
Number of subjects: 193
Study 11124353 — intervention group
Group type: EXPERIMENTAL
Intervention: Analog number representations in young children
Number of subjects: 0
Study 9205921 — intervention group
Group type: EXPERIMENTAL
Intervention: Snakebrush
Number of subjects: 60
Study 9205921 — intervention group
Group type: COMPARATOR
Intervention: Flexible brush
Number of subjects: 60
Study 9205921 — intervention group
Group type: COMPARATOR
Intervention: Precision brush
Number of subjects: 60
Study 8201080 — intervention group
Group type: EXPERIMENTAL
Intervention: On-task and coping thoughts in children with high test anxiety
Number of subjects: 0
Study 8201080 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive self-evaluations
Number of subjects: 0
Study 8201080 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive cognition
Number of subjects: 0
Study 2452564 — intervention group
Group type: EXPERIMENTAL
Intervention: Prourokinase (7.5 mg bolus + 40.5 mg infusion over 60 minutes)
Number of subjects: 54
Study 2452564 — intervention group
Group type: EXPERIMENTAL
Intervention: Prourokinase (7.5 mg bolus + 66.5 mg infusion over 60 minutes)
Number of subjects: 54
Study 2452564 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of prourokinase (3.7 mg bolus + 250,000 IU urokinase + 44.3 mg prourokinase)
Number of subjects: 54
Study 31617568 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-dose (2D) quadrivalent HPV vaccine
Number of subjects: 103
Study 31617568 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-dose (3D) quadrivalent HPV vaccine
Number of subjects: 103
Study 31617568 — intervention group
Group type: COMPARATOR
Intervention: 3-dose (3D) quadrivalent HPV vaccine in women aged 16-26
Number of subjects: 103
Study 28918395 — intervention group
Group type: EXPERIMENTAL
Intervention: nHFOV
Number of subjects: 26
Study 28918395 — intervention group
Group type: COMPARATOR
Intervention: nCPAP
Number of subjects: 26
Study 27107326 — intervention group
Group type: EXPERIMENTAL
Intervention: Eribulin
Number of subjects: 154
Study 26424362 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Imagery and Music (GIM)
Number of subjects: 20
Study 26424362 — intervention group
Group type: COMPARATOR
Intervention: wait-list control
Number of subjects: 20
Study 24227740 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient with focal lesion of the right postcentral gyrus
Number of subjects: 1
Study 24227740 — intervention group
Group type: COMPARATOR
Intervention: Age-matched controls
Number of subjects: 1
Study 24227740 — intervention group
Group type: COMPARATOR
Intervention: Right-hemisphere stroke patients (group analysis)
Number of subjects: 1
Study 21400636 — intervention group
Group type: EXPERIMENTAL
Intervention: Media literacy programme (n=143)
Number of subjects: 443
Study 21400636 — intervention group
Group type: EXPERIMENTAL
Intervention: Media literacy plus nutrition awareness programme (n=99)
Number of subjects: 443
Study 21400636 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=201)
Number of subjects: 443
Study 18188711 — intervention group
Group type: EXPERIMENTAL
Intervention: rhEPOalpha treatment (n = 50)
Number of subjects: 108
Study 18188711 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 58)
Number of subjects: 108
Study 18188711 — intervention group
Group type: EXPERIMENTAL
Intervention: EPO receptor protein expression
Number of subjects: 108
Study 18188711 — intervention group
Group type: EXPERIMENTAL
Intervention: Ki-67 index
Number of subjects: 108
Study 18188711 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic inflammation (ESR)
Number of subjects: 108
Study 16949494 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute serial cardioversion
Number of subjects: 144
Study 16949494 — intervention group
Group type: COMPARATOR
Intervention: Routine serial cardioversion
Number of subjects: 144
Study 16949494 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 144
Study 16949494 — intervention group
Group type: COMPARATOR
Intervention: Digoxin
Number of subjects: 144
Study 12612902 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical therapy plus TIPS
Number of subjects: 109
Study 12612902 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 109
Study 10565650 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin tissue adhesive
Number of subjects: 58
Study 10565650 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard means of hemostasis)
Number of subjects: 58
Study 8740106 — intervention group
Group type: COMPARATOR
Intervention: Miconazole oral gel (Daktar, Janssen)
Number of subjects: 95
Study 8740106 — intervention group
Group type: EXPERIMENTAL
Intervention: Nystatin oral gel (Candio‐Hermal)
Number of subjects: 95
Study 8740106 — intervention group
Group type: EXPERIMENTAL
Intervention: Nystatin oral gel (Lederlind)
Number of subjects: 95
Study 8740106 — intervention group
Group type: COMPARATOR
Intervention: Overall mycologic cure rate
Number of subjects: 95
Study 1831972 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive treatment (with or without relaxation training)
Number of subjects: 58
Study 1831972 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural treatment (with or without relaxation training)
Number of subjects: 58
Study 1831972 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined psychological/physiotherapy treatment conditions
Number of subjects: 58
Study 1831972 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural conditions
Number of subjects: 58
Study 1831972 — intervention group
Group type: COMPARATOR
Intervention: Attention (physiotherapy plus discussion sessions)
Number of subjects: 58
Study 1831972 — intervention group
Group type: COMPARATOR
Intervention: No-attention (physiotherapy-only)
Number of subjects: 58
Study 6129364 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet low in fat (23% of energy) with a high polyunsaturated/saturated (P/S) ratio (1.0)
Number of subjects: 57
Study 6129364 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced daily salt intake from 192 mmol to 77 mmol
Number of subjects: 57
Study 6129364 — intervention group
Group type: COMPARATOR
Intervention: Usual diet (control group)
Number of subjects: 57
Study 30531779 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular revascularization (ER) with SFA stenting
Number of subjects: 234
Study 30531779 — intervention group
Group type: COMPARATOR
Intervention: Loop endarterectomy (LE)
Number of subjects: 234
Study 27063247 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (5mg·kg(‐1))
Number of subjects: 13
Study 27063247 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 24985938 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular preoperative beta blockers
Number of subjects: 69
Study 24985938 — intervention group
Group type: COMPARATOR
Intervention: No preoperative beta blockers (Control)
Number of subjects: 69
Study 24985938 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipsilateral moderate carotid stenosis (60-80%)
Number of subjects: 69
Study 24985938 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative hemodynamic values
Number of subjects: 69
Study 22261362 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional chemoradiotherapy (70 Gy in 7 weeks plus three cycles of 4 days' concomitant carboplatin‐fluorouracil)
Number of subjects: 840
Study 22261362 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated radiotherapy‐chemotherapy (70 Gy in 6 weeks plus two cycles of 5 days' concomitant carboplatin‐fluorouracil)
Number of subjects: 840
Study 22261362 — intervention group
Group type: EXPERIMENTAL
Intervention: Very accelerated radiotherapy (64·8 Gy [1·8 Gy twice daily] in 3·5 weeks)
Number of subjects: 840